- Home
- SHPH vs HSDT Comparison
SHPH vs HSDT Comparison
Compare SHPH & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHPH
- HSDT
- Stock Information
- Founded
- SHPH 2012
- HSDT 2014
- Country
- SHPH United States
- HSDT United States
- Employees
- SHPH N/A
- HSDT N/A
- Industry
- SHPH Biotechnology: Pharmaceutical Preparations
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SHPH Health Care
- HSDT Health Care
- Exchange
- SHPH Nasdaq
- HSDT Nasdaq
- Market Cap
- SHPH 3.1M
- HSDT 3.0M
- IPO Year
- SHPH 2022
- HSDT N/A
- Fundamental
- Price
- SHPH $1.17
- HSDT $0.55
- Analyst Decision
- SHPH
- HSDT Strong Buy
- Analyst Count
- SHPH 0
- HSDT 1
- Target Price
- SHPH N/A
- HSDT $24.00
- AVG Volume (30 Days)
- SHPH 141.0K
- HSDT 499.3K
- Earning Date
- SHPH 11-12-2024
- HSDT 11-07-2024
- Dividend Yield
- SHPH N/A
- HSDT N/A
- EPS Growth
- SHPH N/A
- HSDT N/A
- EPS
- SHPH N/A
- HSDT N/A
- Revenue
- SHPH N/A
- HSDT $594,000.00
- Revenue This Year
- SHPH N/A
- HSDT $16.41
- Revenue Next Year
- SHPH N/A
- HSDT $77.67
- P/E Ratio
- SHPH N/A
- HSDT N/A
- Revenue Growth
- SHPH N/A
- HSDT N/A
- 52 Week Low
- SHPH $1.13
- HSDT $0.51
- 52 Week High
- SHPH $5.35
- HSDT $9.50
- Technical
- Relative Strength Index (RSI)
- SHPH 30.09
- HSDT 31.78
- Support Level
- SHPH $1.29
- HSDT $0.51
- Resistance Level
- SHPH $1.37
- HSDT $0.55
- Average True Range (ATR)
- SHPH 0.12
- HSDT 0.06
- MACD
- SHPH 0.01
- HSDT -0.03
- Stochastic Oscillator
- SHPH 4.93
- HSDT 12.76
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.